当前位置:首页 - 行情中心 - 瑞康医药(002589) - 财务分析 - 现金流量表

瑞康医药

(002589)

  

流通市值:40.01亿  总市值:44.09亿
流通股本:13.66亿   总股本:15.05亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,882,424,602.097,891,061,764.256,050,813,443.423,928,977,071.76
  客户存款和同业存放款项净增加额-0--
  向中央银行借款净增加额-0--
  向其他金融机构拆入资金净增加额-0--
  收到原保险合同保费取得的现金-0--
  收到再保险业务现金净额-0--
  保户储金及投资款净增加额-0--
  收取利息、手续费及佣金的现金-0--
  拆入资金净增加额-0--
  回购业务资金净增加额-0--
  收到的税费返还07,099,709.6818,391.22-
  收到其他与经营活动有关的现金87,892,457.47307,955,980.87141,197,297.15126,836,780.02
  经营活动现金流入的其他项目-0--
  经营活动现金流入小计1,970,317,059.568,206,117,454.86,192,029,131.794,055,813,851.78
  购买商品、接受劳务支付的现金1,762,239,1986,803,688,542.715,531,372,827.893,556,767,619.56
  客户贷款及垫款净增加额-0--
  存放中央银行和同业款项净增加额-0--
  支付原保险合同赔付款项的现金-0--
  支付利息、手续费及佣金的现金-0--
  支付保单红利的现金-0--
  支付给职工以及为职工支付的现金71,456,107.29294,047,562.04212,858,232.01142,824,353.88
  支付的各项税费39,415,965.57142,563,410.5996,633,053.0270,126,414.25
  支付其他与经营活动有关的现金94,988,863.72952,058,412.38310,588,836.18218,209,365.55
  经营活动现金流出的其他项目-0--
  经营活动现金流出小计1,968,100,134.588,192,357,927.726,151,452,949.13,987,927,753.24
  经营活动产生的现金流量净额2,216,924.9813,759,527.0840,576,182.6967,886,098.54
二、投资活动产生的现金流量:
  收回投资收到的现金-00-
  取得投资收益收到的现金1,572,693.15597,850.320,513,453.578,806,344.08
  处置固定资产、无形资产和其他长期资产收回的现金净额685,769.75532,730.1417,109,490.4615,310,562.86
  处置子公司及其他营业单位收到的现金净额15,022,608.4781,840,460.1454,751,353.3537,377,573.48
  收到的其他与投资活动有关的现金350,000,0001,615,420,000280,000,000170,000,000
  投资活动现金流入小计367,281,071.371,698,391,040.58372,374,297.38231,494,480.42
  购建固定资产、无形资产和其他长期资产支付的现金11,145,29426,820,905.2499,479,265.7377,126,743.96
  投资支付的现金100,000,000120,000,000--
  质押贷款净增加额-0--
  取得子公司及其他营业单位支付的现金00--
  支付其他与投资活动有关的现金350,000,0001,603,371,902.07400,000,000290,000,000
  投资活动现金流出小计461,145,2941,750,192,807.31499,479,265.73367,126,743.96
  投资活动产生的现金流量净额-93,864,222.63-51,801,766.73-127,104,968.35-135,632,263.54
三、筹资活动产生的现金流量:
  吸收投资收到的现金020,000,00020,000,00020,000,000
  其中:子公司吸收少数股东投资收到的现金020,000,00020,000,00020,000,000
  取得借款收到的现金1,306,688,4003,361,178,255.692,185,382,046.771,788,053,603.21
  收到其他与筹资活动有关的现金3,016,499,781.5217,466,819,244.0311,131,983,290.377,320,684,452.83
  筹资活动现金流入小计4,323,188,181.5220,847,997,499.7213,337,365,337.149,128,738,056.04
  偿还债务支付的现金964,441,191.73,679,002,430.673,250,924,326.482,289,329,415.89
  分配股利、利润或偿付利息支付的现金77,831,827.04245,569,898.23181,126,511.31119,097,382.51
  其中:子公司支付给少数股东的股利、利润071,070,616.2821,000,000-
  支付其他与筹资活动有关的现金2,988,136,649.3316,857,466,870.2710,018,814,417.636,574,377,996.81
  筹资活动现金流出小计4,030,409,668.0720,782,039,199.1713,450,865,255.428,982,804,795.21
  筹资活动产生的现金流量净额292,778,513.4565,958,300.55-113,499,918.28145,933,260.83
四、汇率变动对现金及现金等价物的影响-0--
五、现金及现金等价物净增加额201,131,215.827,916,060.9-200,028,703.9478,187,095.83
  加:期初现金及现金等价物余额718,238,986.97690,322,926.07690,322,926.07690,322,926.07
  期末现金及现金等价物余额919,370,202.77718,238,986.97490,294,222.13768,510,021.9
补充资料:
  净利润-43,902,130.25-30,605,041.88
  资产减值准备-26,501,315.05--53,240,838.15
  固定资产和投资性房地产折旧-111,981,410.17-58,460,173.46
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-111,981,410.17-58,460,173.46
  无形资产摊销-64,798,703.77-28,045,236.08
  长期待摊费用摊销-16,704,632.15-9,269,254.63
  处置固定资产、无形资产和其他长期资产的损失--1,817,272.56--173,176.52
  固定资产报废损失-707,229.23--1,486,722.43
  公允价值变动损失--4,902,905.63-890,896.12
  财务费用-186,867,399.22-117,884,999.14
  投资损失--84,806,805.99--12,404,896.21
  递延所得税--40,373,226.76--45,300,699.75
  其中:递延所得税资产减少--36,834,552.13--42,678,969.24
    递延所得税负债增加--3,538,674.63--2,621,730.51
  存货的减少-15,804,643--77,583,304.12
  经营性应收项目的减少-439,059,669.3--98,682,537.85
  经营性应付项目的增加--763,019,695.96-110,657,557.8
  现金的期末余额-718,238,986.97-768,510,021.9
  减:现金的期初余额-690,322,926.07-690,322,926.07
  现金及现金等价物的净增加额-27,916,060.9-78,187,095.83
公告日期2026-04-252026-04-232025-10-302025-08-26
审计意见(境内)标准无保留意见
TOP↑